Characteristics and Outcomes of Japanese Encephalitis in the Northeast State of India: A Retrospective Case Series Study

Document Type : Case Series

Authors

Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Kamrup, Assam, India

Abstract
Background: Japanese Encephalitis (JE) is a serious public health issue in an Asian region, causing high mortality and disability rates across all age groups.
Objectives: The current study aims to examine the clinical characteristics, laboratory findings, treatment patterns, and discharge outcomes of JE-admitted patients at a tertiary care neurology hospital in the Northeast state of India.
Methods: The medical records of diagnosed JE patients were reviewed retrospectively between January 2021 and December 2022. Demographic and clinical characteristics were analyzed. Characteristics of the disease severity were assessed based on the discharge status: routine discharge, Discharge Against Medical Advice (DAMA), and mortality during the hospital stay.
Results: A total of 28 JE patients were included; their average age was 40.7 (±20.2) years, males predominantly (60.7%), and the majority belonged to the lower socioeconomic level (85.6%). The most common clinical symptom was fever with altered sensorium (89.3%), with involved hyperintensities in the thalamus (25.0%). Twenty-six patients required Neurological Intensive Care Unit (Neuro-ICU) management with tracheostomy-assisted ventilation due to neurological deterioration. Symptomatic treatment was prescribed such as prophylactic antibiotics and osmotic diuretics. JE patients’ mortality (25.0%) during a hospital stay due to superadded septic shock and elevated intracranial pressure, 21.4% were routine discharge, and 53.6% underwent DAMA.
Conclusion: The prevalent reasons for JE patient mortality were superadded septic shock, increased intracranial pressure, and disease severity. Fever with altered sensorium and thalamus involvement were major findings. Many patients were DAMA because of their low socioeconomic level, which was a barrier to monitoring the progression of the disease.

Keywords


  1. Simon LV, Sandhu DS, Goyal A, Kruse B. Japanese Encephalitis. Treasure Island (FL): StatPearls Publishing LLC.; 2022.
  2. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(10):766-74. doi:10.2471/blt.10.085233
  3. Auerswald H, Maquart PO, Chevalier V, Boyer S. Mosquito vector competence for Japanese encephalitis virus. Viruses. 2021;13(6):1154. doi:10.3390/v13061154
  4. Kulkarni R, Sapkal GN, Kaushal H, Mourya DT. Suppl-2, M8: Japanese encephalitis: A brief review on Indian perspectives. Open Virol J. 2018;12:121-30. doi:2174/ 1874357901812010121
  5. Khan SA, Choudhury P, Kakati S, Doley R, Barman MP, Murhekar MV, et al. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012–2018. Vaccine. 2021;39(35):4973-8. doi:10.1016/j. vaccine.2021.07.041
  6. Tandale BV, Khan SA, Kushwaha KP, Rahman H, Gore MM, Sapkal GN, et al. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1: 4 matched case-control study. J Infect Public Health. 2018;11(5):713-9. doi:10.1016/j.jiph.2018.04.011
  7. Dutta P, Khan SA, Khan AM, Borah J, Sarmah CK, Mahanta J. The effect of insecticide-treated mosquito nets (ITMNs) on Japanese encephalitis virus seroconversion in pigs and humans. Am J Trop Med Hyg. 2011;84(3):466-72. doi:42 69/ajtmh.2011.10-0270
  8. Sunwoo JS, Lee ST, Jung KH, Park KI, Moon J, Jung KY, Kim M, et al. Clinical characteristics of severe Japanese encephalitis: a case series from South Korea. Am J Trop Med Hyg. 2017;97(2):369-75. doi:4269/ajtmh.17-0054
  9. Li D, Zhang X, Shi T, Jin N, Zhao X, Meng L, et al. A comparison of clinical manifestations of Japanese encephalitis between children and adults in Gansu Province, Northwest China (2005–2020). Acta Trop. 2022;231: 106449. doi:10.1016/j.actatropica.2022.106449
  10. Ajibowo AO, Ortiz JF, Alli A, Halan T, Kolawole OA. Management of Japanese encephalitis: A current update. Cureus. 2021;13(4): doi:10.7759/cureus.14579
  11. Roberts, I. Nelson’s textbook of pediatrics (20th edition), by R. Kliegman, B. Stanton, J. St. Geme, N. Schor (eds). Pediatr Radiol. 47, 2017;1364-1365.
  12. Sood P, Bindra S. Modified Kuppuswamy socioeconomic scale: 2022 update of India. Int J Community Med Public Health. 2022;9:3841.
  13. Jain S, Iverson LM. Glasgow Coma Scale. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
  14. Borah J, Dutta P, Khan SA, Mahanta J. A comparison of clinical features of Japanese encephalitis virus infection in the adult and pediatric age group with Acute Encephalitis Syndrome. J Clin Virol. 2011;52(1):45-9. doi:10.1016/ j.jcv.2011.06.001
  15. Kamath SD, Jha B, Ahmed T, Sarkar N, KAMATH SD. A Profile Study of Japanese Encephalitis in an Industrial Hospital in Eastern India. Cureus. 2023;15(5): doi:10.7759/cureus.38455
  16. Lahre Y, Prasad U, Bodra D. High mortality and morbidity of Japanese encephalitis among adults of Jharkhand: need for awareness and vaccination. J Assoc Physicians India. 2020;68(1):92.
  17. Bandyopadhyay B, Bhattacharyya I, Adhikary S, Mondal S, Konar J, Dawar N, et al. Incidence of Japanese encephalitis among acute encephalitis syndrome cases in West Bengal, India. Biomed Res Int. 2013;2013:896749. doi:10.1155/2 013/896749
  18. Gould DJ, Edelman R, Grossman RA, Nisalak A, Sullivan MF. Study of Japanese encephalitis virus in ChiangMai valley, Thailand IV. Vector studies. Am J Epidemiol. 1974;100(1): 49-56. doi:10.1093/oxfordjournals.aje.a112008
  19. Kumari R, Kumar K, Rawat A, Singh G, Yadav NK, Chauhan LS. First indigenous transmission of Japanese Encephalitis in urban areas of National Capital Territory of Delhi, India. Trop Med Int Health. 2013;18(6):743-9. doi:10.1111/tmi.1 2104
  20. Arindam S, Debjani T, Bansi B M, Manish K, Subhra K M, Shyamalendu C. Influence of socio-economic status and environmental factors on serologically diagnosed Japanese encephalitis cases in the state of West Bengal, India during 2005-2010. Health. 2012;2012:16985. doi:10.4236/health. 2012.41002
  21. Verma A, Ahmed Z, Shekhar S, Ahsan M. Spectrum analysis of cases of Japanese encephalitis in Jharkhand, India. IOSR J Dent Med Sci. 2017;16:16-9. doi:10.9790/0853-16030 41619
  22. Solomon T, Dung NM, Kneen R, Thao LT, Gainsborough M, Nisalak A, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002;125(5):1084-93. doi:10.1093/brain/awf116
  23. Griffiths MJ, Lemon JV, Rayamajhi A, Poudel P, Shrestha P, Srivastav V, et al. The functional, social and economic impact of acute encephalitis syndrome in Nepal–a longitudinal follow-up study. PLoS Negl Trop Dis. 2013;7(9): e2383. doi:10.1371/journal.pntd.0002383
  24. Ding D, Hong Z, Zhao SJ, Clemens JD, Zhou B, Wang B, Huang MS, Zeng J, Guo QH, Liu W, Tao FB. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg. 2007;77(3):528-33.
  25. Poneprasert B. Japanese encephalitis in children in northern Thailand. Southeast Asian J Trop Med Public Health. 1989;20(4):599-603.
  26. Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother. 2014;10(2):263-79. doi:10.4161/hv.26902
  27. Payne CF, Davies JI, Gomez-Olive FX, Hands KJ, Kahn K, Kobayashi LC, et al. Cross-sectional relationship between haemoglobin concentration and measures of physical and cognitive function in an older rural South African population. J Epidemiol Community Health. 2018;72(9):796-802. doi:10.1136/jech-2018-210449
  28. Son H, Sunwoo JS, Lee SK, Chu K, Lee ST. Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α J Clin Neurol. 2021;17(3):428-34. doi:10.3988/jcn.2021. 17.3.428
  29. Chen KM, Tsai HC, Sy CL, Lee SS, Liu YC, Wann SR, et al. Clinical manifestations of Japanese encephalitis in southern Taiwan. J Microbiol Immunol Infect. 2009;42(4):296-302.
  30. Misra UK, Kalita J, Goel D, Mathur A. Clinical, radiological and neurophysiological spectrum of JEV encephalitis and other non-specific encephalitis during post-monsoon period in India. Neurol India. 2003;51(1):55-9.
  31. Kalita J, Misra UK, Pandey S, Dhole TN. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol. 2003;60(12):1760-4. doi:10.1001/archneur.60.12.1760
  32. Sarkari NB, Thacker AK, Barthwal SP, Mishra VK, Prapann S, Srivastava D, et al. Japanese encephalitis (JE) part II: 14 years’ follow-up of survivors. J Neurol. 2012;259:58-69. doi:10.1007/s00415-011-6131-9
  33. Pichl T, Wedderburn CJ, Hoskote C, Turtle L, Bharucha T. A systematic review of brain imaging findings in neurological infection with Japanese encephalitis virus compared with Dengue virus. Int J Infect Dis. 2022;119:102-10. doi:10.1016/j.ijid.2022.03.010
  34. Dwibedi B, Mohapatra N, Rathore SK, Panda M, Pati SS, Sabat J, et al. An outbreak of Japanese encephalitis after two decades in Odisha, India. Indian J Med Res. 2015;142(Suppl 1):S30-S32. doi:10.4103/0971-5916.176609